
Over eight months, Ben Spratt contributed to the ProteoWizard/pwiz repository, focusing on mass spectrometry data processing, library integration, and workflow stability. He enhanced GC-MS and Bruker DiaPASEF support, expanded MSP library parsing, and implemented robust error handling for data import and validation. Using C#, C++, and XML, Ben addressed concurrency issues, improved test automation, and optimized CI/CD processes. His work included refining UI elements, strengthening data parsing logic, and centralizing retention time management. By prioritizing maintainable code and reliable data handling, Ben delivered features and fixes that improved analytical accuracy and reduced runtime errors across complex mass spectrometry workflows.

October 2025: The pwiz team delivered significant features and robustness improvements across MSP parsing, CNL-capable spectrum filtering, and library validation. This work broadens library format compatibility, enables robust chromatogram extraction for precursor+CNL combinations, and reduces runtime crashes due to invalid entries, delivering tangible business value in data quality, processing reliability, and Skyline integration.
October 2025: The pwiz team delivered significant features and robustness improvements across MSP parsing, CNL-capable spectrum filtering, and library validation. This work broadens library format compatibility, enables robust chromatogram extraction for precursor+CNL combinations, and reduces runtime crashes due to invalid entries, delivering tangible business value in data quality, processing reliability, and Skyline integration.
September 2025: ProteoWizard/pwiz monthly highlights focusing on expanding GC-MS EI workflows, strengthening Bruker DiaPASEF support, and improving robustness and test hygiene. Delivered Electron Ionization (EI) acquisition in GC-MS enabling EI workflows by treating MS1 as fragmented MS2 when EI is selected, with UI cues and tooltips. Enhanced Bruker DiaPASEF support to cover Diagonal and MiDia modes, improved window selection, and ensured MS2 data handling; addressed buffer overrun in all-ions mode and fortified test reliability. Fixed MS1 FullScan greyout when EI is active and corrected hard-coded paths in Diagonal PASEF tests. These changes increase data quality, enable new acquisition strategies, and reduce regression risk, delivering measurable business value by expanding analytical capabilities and improving reliability across GC-MS and DiaPASEF workflows.
September 2025: ProteoWizard/pwiz monthly highlights focusing on expanding GC-MS EI workflows, strengthening Bruker DiaPASEF support, and improving robustness and test hygiene. Delivered Electron Ionization (EI) acquisition in GC-MS enabling EI workflows by treating MS1 as fragmented MS2 when EI is selected, with UI cues and tooltips. Enhanced Bruker DiaPASEF support to cover Diagonal and MiDia modes, improved window selection, and ensured MS2 data handling; addressed buffer overrun in all-ions mode and fortified test reliability. Fixed MS1 FullScan greyout when EI is active and corrected hard-coded paths in Diagonal PASEF tests. These changes increase data quality, enable new acquisition strategies, and reduce regression risk, delivering measurable business value by expanding analytical capabilities and improving reliability across GC-MS and DiaPASEF workflows.
Concise monthly summary for July 2025 focused on ProteoWizard/pwiz SSL data processing robustness and protein metadata resolution, highlighting business value and technical achievements.
Concise monthly summary for July 2025 focused on ProteoWizard/pwiz SSL data processing robustness and protein metadata resolution, highlighting business value and technical achievements.
March 2025 was focused on improving stability and correctness for mz-based search in ProteoWizard/pwiz. Implemented a polarity-aware precursor m/z search bug fix, added automated tests, and tightened polarity handling to prevent exceptions in mixed-polarity documents. These changes reduce runtime errors and improve reliability for downstream analyses.
March 2025 was focused on improving stability and correctness for mz-based search in ProteoWizard/pwiz. Implemented a polarity-aware precursor m/z search bug fix, added automated tests, and tightened polarity handling to prevent exceptions in mixed-polarity documents. These changes reduce runtime errors and improve reliability for downstream analyses.
February 2025: Stability and performance improvements for ProteoWizard/pwiz. Delivered a critical null-reference fix in the graph update path, enhanced test reliability with a new NoLeakTesting attribute and refined test runner behavior, and optimized parallel test launch to reduce CI overhead when not beneficial. These changes improve runtime stability, testing accuracy, and resource efficiency, accelerating feedback and deployment cycles.
February 2025: Stability and performance improvements for ProteoWizard/pwiz. Delivered a critical null-reference fix in the graph update path, enhanced test reliability with a new NoLeakTesting attribute and refined test runner behavior, and optimized parallel test launch to reduce CI overhead when not beneficial. These changes improve runtime stability, testing accuracy, and resource efficiency, accelerating feedback and deployment cycles.
January 2025 monthly summary for ProteoWizard/pwiz focusing on delivering user-visible improvements, stabilizing data import workflows, and strengthening test infrastructure. Highlighted by data handling and UI formatting enhancements, robust locale- and data-variant handling, and expanded test reliability, all driving reduced user confusion and lower maintenance risk.
January 2025 monthly summary for ProteoWizard/pwiz focusing on delivering user-visible improvements, stabilizing data import workflows, and strengthening test infrastructure. Highlighted by data handling and UI formatting enhancements, robust locale- and data-variant handling, and expanded test reliability, all driving reduced user confusion and lower maintenance risk.
December 2024 (ProteoWizard/pwiz): Consolidated reliability and quality improvements across readers and testing infrastructure, delivering measurable reductions in test flakiness and race-condition risk while strengthening data-processing stability for large-scale workflows. The work emphasizes automated testing reliability, safer multi-threaded data access, and maintainable code health, directly supporting developer productivity and platform trust for downstream users.
December 2024 (ProteoWizard/pwiz): Consolidated reliability and quality improvements across readers and testing infrastructure, delivering measurable reductions in test flakiness and race-condition risk while strengthening data-processing stability for large-scale workflows. The work emphasizes automated testing reliability, safer multi-threaded data access, and maintainable code health, directly supporting developer productivity and platform trust for downstream users.
November 2024 monthly summary for ProteoWizard/pwiz: Delivered focused data-processing enhancements, UI reliability fixes, and developer hygiene improvements that increase the reliability of mass spectrometry analyses and support PFAS research workflows. The work improved data interpretation, reduced manual debugging, and accelerated release readiness for critical workflows in spectral analysis and small-molecule transitions.
November 2024 monthly summary for ProteoWizard/pwiz: Delivered focused data-processing enhancements, UI reliability fixes, and developer hygiene improvements that increase the reliability of mass spectrometry analyses and support PFAS research workflows. The work improved data interpretation, reduced manual debugging, and accelerated release readiness for critical workflows in spectral analysis and small-molecule transitions.
Overview of all repositories you've contributed to across your timeline